pH-responsive curcumin-based nanoscale ZIF-8 combining chemophotodynamic therapy for excellent antibacterial activity.
Xiaofeng MengJingwei GuanShanshan LaiLiming FangJianyu SuPublished in: RSC advances (2022)
Antimicrobial photodynamic therapy (aPDT) is a highly attractive therapy due to its advantages of being a non-antibiotic procedure for reducing drug-resistant microbes. Curcumin (CCM) has been considered as a natural photosensitizer for PDT with prominent antibacterial, antifungal, and anti-proliferative activity. However, its excellent biological and pharmacological activities are limited because of its low solubility, rapid metabolization and instability. Herein, we reported a promising agent based on CCM-incorporated into zeolitic imidazolate framework-8 (ZIF@CCM). The as-prepared nanoparticle exhibited high drug loading capability (11.57%) and drug loading encapsulation (82.76%). Additionally, ZIF@CCM displayed a pH-responsive drug release behavior and chemophotodynamic therapy for excellent antibacterial activity. The underlying mechanism elucidated that Zn 2+ released from ZIF-8 increased the permeability of the bacterial cell membrane with leakages of K + . The overproduction of extracellular ROS further resulted in the disrupted bacterial cell membrane and distorted bacterial morphology. Thus, ZIF@CCM-mediated photodynamic activation might be a promising treatment strategy for microbial inactivation.
Keyphrases
- photodynamic therapy
- drug resistant
- drug release
- multidrug resistant
- silver nanoparticles
- acinetobacter baumannii
- fluorescence imaging
- drug delivery
- staphylococcus aureus
- microbial community
- emergency department
- cell death
- dna damage
- adverse drug
- minimally invasive
- stem cells
- candida albicans
- cancer therapy
- heavy metals
- mass spectrometry
- risk assessment
- reactive oxygen species
- bone marrow
- endothelial cells
- drug induced
- oxidative stress
- cell therapy
- mesenchymal stem cells
- anti inflammatory
- high resolution
- combination therapy